CA
GSK icon

Cetera Advisors’s GSK GSK Stock Holding History

Cetera Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		$2.7M Buy
62,998
+33,642
+115% +$1.39M 0.02% 686
2023
Q4 		$1.09M Sell
29,356
-4,406
-13% -$158K 0.02% 745
2023
Q3 		$1.22M Sell
33,762
-60,501
-64% -$2.15M 0.02% 643
2023
Q2 		$3.36M Sell
94,263
-6,066
-6% -$218K 0.05% 327
2023
Q1 		$3.57M Sell
100,329
-465
-0.5% -$16.3K 0.06% 303
2022
Q4 		$3.54M Buy
100,794
+18,859
+23% +$628K 0.06% 300
2022
Q3 		$2.41M Buy
81,935
+4,073
+5% +$154K 0.06% 318
2022
Q2 		$4.24M Sell
77,862
-287
-0.4% -$15.8K 0.1% 209
2022
Q1 		$4.25M Buy
78,149
+9,192
+13% +$499K 0.08% 249
2021
Q4 		$3.8M Sell
68,957
-9,612
-12% -$500K 0.08% 261
2021
Q3 		$3.75M Buy
78,569
+17,238
+28% +$866K 0.07% 279
2021
Q2 		$3.05M Buy
61,331
+3,352
+6% +$161K 0.07% 277
2021
Q1 		$2.59M Buy
57,979
+5,181
+10% +$235K 0.07% 266
2020
Q4 		$2.43M Buy
52,798
+15,596
+42% +$716K 0.08% 236
2020
Q3 		$1.75M Buy
37,202
+12,579
+51% +$630K 0.07% 270
2020
Q2 		$1.25M Buy
24,623
+536
+2% +$27.5K 0.05% 312
2020
Q1 		$1.14M Sell
24,087
-20,081
-45% -$1.07M 0.06% 298
2019
Q4 		$2.59M Sell
44,168
-697
-2% -$38.8K 0.11% 188
2019
Q3 		$2.4M Buy
44,865
+3,937
+10% +$203K 0.11% 189
2019
Q2 		$2.04M Buy
40,928
+874
+2% +$43.9K 0.09% 212
2019
Q1 		$2.09M Buy
40,054
+26,588
+197% +$1.33M 0.1% 189
2018
Q4 		$643K Buy
13,466
+2,564
+24% +$126K 0.04% 413
2018
Q3 		$543K Buy
10,902
+6,680
+158% +$339K 0.03% 533
2018
Q2 		$209K Sell
4,222
-1,258
-23% -$63.4K 0.01% 794
2018
Q1 		$267K Buy
5,480
+313
+6% +$14.6K 0.02% 649
2017
Q4 		$231K Buy
5,167
+428
+9% +$19.8K 0.01% 673
2017
Q3 		$237K Sell
4,739
-7,751
-62% -$393K 0.01% 695
2017
Q2 		$672K Sell
12,490
-9
-0.1% -$480 0.04% 392
2017
Q1 		$653K Buy
12,499
+4,809
+63% +$244K 0.04% 377
2016
Q4 		$372K Buy
7,690
+422
+6% +$20.8K 0.03% 482
2016
Q3 		$391K Sell
7,268
-288
-4% -$15.8K 0.03% 489
2016
Q2 		$407K Buy
7,556
+365
+5% +$19.2K 0.03% 474
2016
Q1 		$365K Sell
7,191
-7,243
-50% -$361K 0.03% 477
2015
Q4 		$726K Sell
14,434
-829
-5% -$42.3K 0.06% 326
2015
Q3 		$731K Buy
15,263
+806
+6% +$42K 0.07% 287
2015
Q2 		$751K Buy
14,457
+1,805
+14% +$102K 0.06% 311
2015
Q1 		$729K Buy
12,652
+4,518
+56% +$259K 0.07% 310
2014
Q4 		$434K Buy
8,134
+3,400
+72% +$190K 0.04% 394
2014
Q3 		$273K Buy
4,734
+178
+4% +$10.9K 0.02% 473
2014
Q2 		$304K Buy
4,556
+1,381
+43% +$93.5K 0.03% 434
2014
Q1 		$214K Buy
+3,175
New +$215K 0.03% 473

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Holocene Advisors
Holocene Advisors New York $41.5B AUM 42.97% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Cetera Advisors's GSK Position: Q1 2024 in Review

Cetera Advisors increased its GSK (GSK) stake by 115% in Q1 2024, buying an estimated $1.39M and bringing the position to 62,998 shares worth $2.7M. The position accounts for 0.02% of the portfolio, ranked #686.

Cetera Advisors first reported a position in GSK in Q1 2014 and has held it in 41 quarters since. The position peaked at $4.25M in Q1 2022. 910 funds tracked by Wall St. Rank hold GSK as of Q1 2024.

  • Cetera Advisors held 62,998 shares of GSK worth $2.7M as of Q1 2024.
  • Cetera Advisors bought 33,642 GSK shares in Q1 2024, an estimated $1.39M.
  • GSK made up 0.02% of Cetera Advisors's portfolio in Q1 2024, its #686 holding.
  • Cetera Advisors first reported a position in GSK in Q1 2014 and has held it in 41 quarters since.
  • Cetera Advisors's GSK position peaked at $4.25M in Q1 2022.
  • 910 funds tracked by Wall St. Rank held GSK as of Q1 2024.

Based on Cetera Advisors's 13F filing for Q1 2024, filed 15 May 2024.